share_log

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

PR Newswire ·  Apr 1 09:00
DELFI Diagnostics, Inc. (PRNewsfoto/DELFI Diagnostics)
FirstLook Lung is a new blood test that offers a convenient, accessible, and personalized approach to enhance lung cancer screening. FirstLook helps determine the likelihood of detecting lung cancer through low-dose CT (LDCT), with a negative predictive value of 99.8%.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment